Human assessment

 

A randomized, double blind, placebo controlled clinical study has been performed with Ellirose™.  This study adds further evidence that Ellirose™ may help support a healthy urinary tract.

Allaert F.A. 2010,  Lettre de l’infectiologue, Tome XXV, N°2: 56-60

 

1. KEY RESULT ON URINARY FUNCTION

This clinical study evaluated the recurrence of urinary infections among women who are particularly susceptible to reoccurring episodes. The results were evaluated after 3 and 6 months with a supplementation with Ellirose™.

 

Conclusion: The frequency of urinary infections reported reduced significantly with Ellirose™ compared to 3 months before the study started. After 6 months urinary infections were reduced by 89%. The reduction in frequency is all the more significant versus placebo at 6 months (p<0.01).

 

 

2. SUPPLEMENTATION BENEFITS

In the study, doctors also evaluated the benefit of the supplementation on the urinary wellbeing of women.

 

Conclusion: Doctors considered that the supplementation of Ellirose™ was significantly improving urinary women wellbeing in 68% of patients versus only 22% for the placebo.